Tülin Özkan

610 total citations
47 papers, 408 citations indexed

About

Tülin Özkan is a scholar working on Molecular Biology, Hematology and Organic Chemistry. According to data from OpenAlex, Tülin Özkan has authored 47 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 17 papers in Hematology and 11 papers in Organic Chemistry. Recurrent topics in Tülin Özkan's work include Chronic Myeloid Leukemia Treatments (11 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Quinazolinone synthesis and applications (6 papers). Tülin Özkan is often cited by papers focused on Chronic Myeloid Leukemia Treatments (11 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Quinazolinone synthesis and applications (6 papers). Tülin Özkan collaborates with scholars based in Türkiye, Iran and Czechia. Tülin Özkan's co-authors include Asuman Sunguroğlu, Yalda Hekmatshoar, Arzu Zeynep Karabay, Fügen Aktan, Sena Aydos, Yalda Rahbar Saadat, Seyed Mahdi Hosseiniyan Khatibi, Bahram Pourghassem Gargari, Hakan Göker and Sepideh Zununi Vahed and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and International Journal of Molecular Sciences.

In The Last Decade

Tülin Özkan

45 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tülin Özkan Türkiye 12 212 59 56 55 41 47 408
Maria Paola Smacchia Italy 6 164 0.8× 73 1.2× 49 0.9× 53 1.0× 40 1.0× 12 446
Donghu Zhou China 11 179 0.8× 67 1.1× 34 0.6× 34 0.6× 82 2.0× 31 363
Xiaoying Zhao China 13 245 1.2× 86 1.5× 42 0.8× 89 1.6× 70 1.7× 35 501
Emily A. Smith United States 9 142 0.7× 72 1.2× 26 0.5× 20 0.4× 28 0.7× 28 460
Kavitha Godugu United States 12 136 0.6× 62 1.1× 18 0.3× 67 1.2× 41 1.0× 29 350
Haydar Çelik United States 13 232 1.1× 79 1.3× 20 0.4× 39 0.7× 48 1.2× 27 447
Alireza Mohseni Iran 9 132 0.6× 24 0.4× 111 2.0× 86 1.6× 26 0.6× 20 379
Bing Xia China 13 219 1.0× 127 2.2× 43 0.8× 89 1.6× 56 1.4× 51 505
Sima Mansoori Derakhshan Iran 5 325 1.5× 69 1.2× 27 0.5× 20 0.4× 103 2.5× 22 533

Countries citing papers authored by Tülin Özkan

Since Specialization
Citations

This map shows the geographic impact of Tülin Özkan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tülin Özkan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tülin Özkan more than expected).

Fields of papers citing papers by Tülin Özkan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tülin Özkan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tülin Özkan. The network helps show where Tülin Özkan may publish in the future.

Co-authorship network of co-authors of Tülin Özkan

This figure shows the co-authorship network connecting the top 25 collaborators of Tülin Özkan. A scholar is included among the top collaborators of Tülin Özkan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tülin Özkan. Tülin Özkan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Özkan, Tülin, et al.. (2024). Synthesis of novel indol-3-acetamido analogues as potent anticancer agents, biological evaluation and molecular modeling studies. Bioorganic Chemistry. 148. 107429–107429. 1 indexed citations
2.
Hekmatshoar, Yalda, et al.. (2024). Methylsulfonylmethane induces caspase‐dependent apoptosis in acute myeloid leukemia cell lines. Fundamental and Clinical Pharmacology. 38(6). 1094–1102. 2 indexed citations
4.
Hekmatshoar, Yalda, Tülin Özkan, Sena Aydos, et al.. (2023). DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA. Mediterranean Journal of Hematology and Infectious Diseases. 15(1). e2023008–e2023008. 1 indexed citations
5.
Özkan, Tülin, et al.. (2023). HIV‐1 integrase inhibitor raltegravir promotes DNA damage‐induced apoptosis in multiple myeloma. Chemical Biology & Drug Design. 102(2). 262–270. 7 indexed citations
6.
Nakhle, Jean, Tülin Özkan, Amélie Darlix, et al.. (2023). Mitochondria Transfer from Mesenchymal Stem Cells Confers Chemoresistance to Glioblastoma Stem Cells through Metabolic Rewiring. Cancer Research Communications. 3(6). 1041–1056. 31 indexed citations
7.
Hekmatshoar, Yalda, et al.. (2023). Identification of common genes and pathways underlying imatinib and nilotinib treatment in CML: a Bioinformatics Study. Nucleosides Nucleotides & Nucleic Acids. 43(7). 664–684. 2 indexed citations
8.
Hekmatshoar, Yalda, et al.. (2023). Phenotypic and functional characterization of subpopulation of Imatinib resistant chronic myeloid leukemia cell line. Advances in Medical Sciences. 68(2). 238–248. 2 indexed citations
10.
Özkan, Tülin, et al.. (2022). Werner helicase is required for proliferation and DNA damage repair in multiple myeloma. Molecular Biology Reports. 50(2). 1565–1573. 2 indexed citations
11.
Özkan, Tülin, et al.. (2021). Assessment of azithromycin as an anticancer agent for treatment of imatinib sensitive and resistant CML cells. Leukemia Research. 102. 106523–106523. 21 indexed citations
12.
Hekmatshoar, Yalda, Yalda Rahbar Saadat, Seyed Mahdi Hosseiniyan Khatibi, et al.. (2019). The impact of tumor and gut microbiotas on cancer therapy: Beneficial or detrimental?. Life Sciences. 233. 116680–116680. 36 indexed citations
13.
Çetinkaya, Şerife Esra, et al.. (2018). Expressions of homeobox, collagen and estrogen genes in women with uterine prolapse. European Journal of Obstetrics & Gynecology and Reproductive Biology. 233. 26–29. 11 indexed citations
14.
Özkan, Tülin, et al.. (2017). Incomplete Antibodies May Reduce ABO Cross-Match Incompatibility: A Pilot Study. Turkish Journal of Hematology. 35(1). 54–60. 1 indexed citations
15.
Aydos, Sena, Yalda Hekmatshoar, Tülin Özkan, et al.. (2017). Genetic Polymorphisms in PRM1 , PRM2 , and YBX2 Genes are Associated with Male Factor Infertility. Genetic Testing and Molecular Biomarkers. 22(1). 55–61. 9 indexed citations
16.
Aydos, Sena, et al.. (2015). Association of MDR1 C3435T and C1236T single nucleotide polymorphisms with male factor infertility. Genetics and Molecular Research. 14(2). 6330–6339. 8 indexed citations
17.
Göker, Hakan, et al.. (2014). Synthesis and anticancer effects of some novel 2-(4-phenoxyphenyl)-1H-benzimidazole derivatives on K562 cell line. Archives of Pharmacal Research. 38(5). 650–658. 11 indexed citations
18.
Göker, Hakan, et al.. (2013). Synthesis and cytotoxic evaluation of novel N-substituted amidino-1-hydroxybenzimidazole derivatives. Archives of Pharmacal Research. 37(5). 580–587. 5 indexed citations
19.
Taşpınar, Mehmet, Mevci̇ Özdemi̇r, Tülin Özkan, et al.. (2013). Effect of lomeguatrib–temozolomide combination on MGMT promoter methylation and expression in primary glioblastoma tumor cells. Tumor Biology. 34(3). 1935–1947. 15 indexed citations
20.
Karabay, Arzu Zeynep, et al.. (2012). Effects of glucosamine on LPS/IFN-γ induced RAW 264.7 macrophage apoptosis. SHILAP Revista de lepidopterología. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026